Related Experiment Video

Updated: Jun 2, 2025

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

34.4K

GTS-21 modulates rheumatoid arthritis Th17 and Th2 lymphocyte subset differentiation through the ɑ7nAch receptor

Shiyao Wu1,2, Yanli Xie1,2, Ying Jiang1,2

  • 1Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.

Clinical Rheumatology
|January 15, 2025
PubMed

Insights

GTS-21, an alpha-7 nicotinic acetylcholine receptor (α7nAChR) agonist, suppresses Th17 cell differentiation and promotes Th2 cell differentiation in rheumatoid arthritis (RA). This suggests GTS-21 may offer a new therapeutic strategy for RA patients by modulating T cell subsets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation.
  • Alpha-7 nicotinic acetylcholine receptor (α7nAChR) agonists have shown potential therapeutic benefits in RA.
  • The precise immunological mechanisms underlying the effects of α7nAChR agonists in RA remain unclear.

Purpose of the Study:

  • To investigate the effect of the selective α7nAChR agonist GTS-21 on Th17 and Th2 cell differentiation in rheumatoid arthritis.
  • To elucidate the immunological mechanism of action of GTS-21 in the context of T cell differentiation relevant to RA pathogenesis.

Main Methods:

  • CD4+ T cells were isolated from peripheral blood mononuclear cells (PBMCs) of RA patients and healthy donors.
  • Cells were differentiated into Th17 or Th2 cells in the presence or absence of GTS-21 and/or the α7nAChR antagonist alpha-bungarotoxin (αBgt).
  • Cell proportions were analyzed by flow cytometry, cytokine levels (IL-17A, IL-4) by ELISA, and transcription factor expression (RORc, GATA-3) by western blot.

Main Results:

  • GTS-21 significantly reduced IL-17A production and Th17 cell differentiation while increasing IL-4 production and Th2 cell differentiation in RA PBMCs.
  • GTS-21 downregulated RORc expression, a key transcription factor for Th17 cells, and upregulated GATA-3 expression, crucial for Th2 cells.
  • The observed effects of GTS-21 were blocked by the α7nAChR antagonist αBgt, confirming the involvement of the α7nAChR pathway.

Conclusions:

  • GTS-21 effectively suppresses Th17 cell differentiation and promotes Th2 cell differentiation in the context of rheumatoid arthritis.
  • These immunomodulatory effects are mediated through the α7nAChR pathway.
  • GTS-21 represents a potential novel therapeutic agent for rheumatoid arthritis, acting by rebalancing T cell subset differentiation.
Keywords:
GTS-21Rheumatoid arthritisTh17 cellsTh2 cellsɑ7nAch receptor

More Related Videos

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation07:46

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

2.8K
Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets07:12

Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets

Published on: April 16, 2015

51.9K

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
647
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K